Action Antiplatelet agent; inhibits thromboxane A2
Status FDA Approved for use in stroke prevention and cardiovascular disease
Trial(s) = Ongoing = Completed
UID: 6
Internet Stroke Center at Washington University: HOME | ABOUT | PRIVACY POLICY | CONTACT
Copyright © 1997-2010 - Internet Stroke Center. All rights reserved. Last modified: Friday, March 12, 2010